Literature DB >> 30651199

Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy.

S Boccalini1, F Mandò Tacconi2, Piero Luigi Lai3, A Bechini2, P Bonanni2, D Panatto4.   

Abstract

In Italy, several types of influenza vaccine are on the market. Available evidence suggests that no single vaccine type is universally appropriate; rather, different types may be more appropriate for different population strata. However, while the concept of appropriateness/preferential use of single vaccines is usually adopted at the central level, little is known about the attitudes of physicians on the matter. A pilot survey of Italian physicians (N = 372) revealed that most (about 90%) were aware that the available vaccines were different, and that particular vaccines were more appropriate for specific groups. The availability of explicit guidelines on which vaccine to administer to a given population group was deemed desirable by 93.2% of respondents. The results were consistent with the 2018 Italian and UK normative documents, which indicate adjuvanted vaccines as the most appropriate choice for the elderly, and quadrivalent formulations for the younger age-classes. Public health policy implications are discussed.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Keywords:  Influenza; Policy; Vaccination

Mesh:

Substances:

Year:  2019        PMID: 30651199     DOI: 10.1016/j.vaccine.2018.12.057

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Strengthening the Evidence-Based Approach to Guiding Effective Influenza Vaccination Policies.

Authors:  Giovanna Elisa Calabrò; Maria Lucia Specchia; Sara Boccalini; Donatella Panatto; Caterina Rizzo; Stefano Merler; Anna Maria Ferriero; Maria Luisa Di Pietro; Paolo Bonanni; Chiara de Waure
Journal:  Vaccines (Basel)       Date:  2020-06-27

2.  Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey.

Authors:  Alexander Domnich; Maura Cambiaggi; Alessandro Vasco; Luca Maraniello; Filippo Ansaldi; Vincenzo Baldo; Paolo Bonanni; Giovanna Elisa Calabrò; Claudio Costantino; Chiara de Waure; Giovanni Gabutti; Vincenzo Restivo; Caterina Rizzo; Francesco Vitale; Riccardo Grassi
Journal:  Vaccines (Basel)       Date:  2020-11-30

3.  Acceptance of COVID-19 and Influenza Vaccine Co-Administration: Insights from a Representative Italian Survey.

Authors:  Alexander Domnich; Riccardo Grassi; Elettra Fallani; Roberto Ciccone; Bianca Bruzzone; Donatella Panatto; Allegra Ferrari; Marco Salvatore; Maura Cambiaggi; Alessandro Vasco; Andrea Orsi; Giancarlo Icardi
Journal:  J Pers Med       Date:  2022-01-20

4.  An exploratory study to assess patterns of influenza- and pneumonia-related mortality among the Italian elderly.

Authors:  Elettra Fallani; Andrea Orsi; Alessio Signori; Giancarlo Icardi; Alexander Domnich
Journal:  Hum Vaccin Immunother       Date:  2021-12-29       Impact factor: 3.452

5.  Factors driving choices between types and brands of influenza vaccines in general practice in Austria, Italy, Spain and the UK.

Authors:  Anke L Stuurman; Sara Ciampini; Alfredo Vannacci; Antonino Bella; Caterina Rizzo; Cintia Muñoz-Quiles; Elisabetta Pandolfi; Harshana Liyanage; Mendel Haag; Monika Redlberger-Fritz; Roberto Bonaiuti; Philippe Beutels
Journal:  PLoS One       Date:  2021-06-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.